Which of the following elements is essential for a compliant Investigational Product (IP) accountability record at a clinical trial site?
-
A
Lot number, expiration date, and quantities received, dispensed, and returned.
-
B
The participant's full name and medical record number for each dispensing event.
-
C
The name and signature of the monitor who last reviewed the records.
-
D
The manufacturing cost and batch release date of the investigational product.